Migdal Insurance & Financial Holdings Ltd. grew its holdings in shares of Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) by 101.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 745,000 shares of the basic materials company’s stock after acquiring an additional 375,000 shares during the quarter. Migdal Insurance & Financial Holdings Ltd.’s holdings in Cameco were worth $68,160,000 at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in CCJ. TD Asset Management Inc increased its stake in shares of Cameco by 116.7% in the third quarter. TD Asset Management Inc now owns 4,622,932 shares of the basic materials company’s stock worth $388,068,000 after buying an additional 2,489,207 shares during the period. Van ECK Associates Corp increased its stake in shares of Cameco by 43.3% in the third quarter. Van ECK Associates Corp now owns 5,443,807 shares of the basic materials company’s stock worth $456,530,000 after buying an additional 1,644,061 shares during the period. Mizuho Markets Cayman LP purchased a new position in shares of Cameco in the third quarter worth $128,370,000. Victory Capital Management Inc. increased its stake in shares of Cameco by 75.8% in the third quarter. Victory Capital Management Inc. now owns 2,489,424 shares of the basic materials company’s stock worth $208,490,000 after buying an additional 1,073,111 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. increased its stake in shares of Cameco by 32.8% in the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 4,291,202 shares of the basic materials company’s stock worth $360,063,000 after buying an additional 1,060,842 shares during the period. 70.21% of the stock is owned by hedge funds and other institutional investors.
Cameco Stock Down 5.7%
Shares of Cameco stock opened at $116.54 on Wednesday. The company has a current ratio of 2.47, a quick ratio of 1.68 and a debt-to-equity ratio of 0.14. The company’s fifty day simple moving average is $114.17 and its two-hundred day simple moving average is $103.74. The company has a market cap of $50.76 billion, a P/E ratio of 120.15 and a beta of 1.02. Cameco Corporation has a 12-month low of $39.89 and a 12-month high of $135.24.
Trending Headlines about Cameco
Here are the key news stories impacting Cameco this week:
- Positive Sentiment: William Blair initiated coverage with an Outperform rating and a $165 fair?value estimate, a material bullish endorsement that supports longer?term upside for CCJ. William Blair Initiates Coverage
- Positive Sentiment: Analyst and investor commentary (Seeking Alpha) recommends buying Cameco on dips under ~$120, reinforcing support from income/stability narratives in the nuclear/uranium theme. Buy on Dip Thesis
- Neutral Sentiment: Comparative coverage with peers (Energy Fuels / UUUU) highlights a tradeoff: Cameco offers scale and stability while some rivals offer faster growth and REE exposure — useful context for investors rebalancing within the uranium complex. CCJ vs UUUU Comparison
- Negative Sentiment: Scotiabank trimmed its FY2027 EPS estimate for Cameco marginally (from $1.48 to $1.47), and consensus full?year estimates remain above that level — a modest negative signal for near?term earnings expectations. MarketBeat Coverage
- Negative Sentiment: Market?coverage pieces reported that CCJ posted a larger intraday decline than the broader market, reflecting short?term profit taking or rotation away from cyclicals despite the bullish initiation. Zacks: Larger Drop Report
Analyst Ratings Changes
Several brokerages recently commented on CCJ. Zacks Research downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 18th. Weiss Ratings raised shares of Cameco from a “hold (c)” rating to a “buy (b-)” rating in a research note on Monday, February 23rd. TD Securities downgraded shares of Cameco from a “strong-buy” rating to a “hold” rating in a research note on Thursday, March 26th. Glj Research reaffirmed a “buy” rating and issued a $171.20 target price (up from $100.00) on shares of Cameco in a research note on Wednesday, February 18th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and issued a $131.00 target price on shares of Cameco in a research note on Wednesday, February 4th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $150.40.
Get Our Latest Stock Analysis on Cameco
Cameco Profile
Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long?term and spot contracts.
The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.
Featured Stories
Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO).
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
